Anavex Life Sciences Faces Securities Class Action Over Alleged Disclosures

Anavex Life Sciences Corp. is the subject of a securities class action, according to a DJS Law Group notice dated Oct. 12, 2026. The firm says investors who bought AVXL during the class period may seek possible lead plaintiff appointments.




